- Home
- SOHU vs AMRN Comparison
SOHU vs AMRN Comparison
Compare SOHU & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SOHU | AMRN |
|---|---|---|
| Founded | 1996 | 1989 |
| Country | China | Ireland |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 324.6M | 287.9M |
| IPO Year | 2018 | 1998 |
Fundamental Metrics
Financial Performance| Metric | SOHU | AMRN |
|---|---|---|
| Price | $12.54 | $11.53 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 2 | 2 |
| Target Price | ★ $19.50 | $12.50 |
| AVG Volume (30 Days) | ★ 84.9K | 51.8K |
| Earning Date | 11-16-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $181,104,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.46 | N/A |
| P/E Ratio | $1.16 | ★ N/A |
| Revenue Growth | N/A | ★ 39.22 |
| 52 Week Low | $11.61 | $11.83 |
| 52 Week High | $17.30 | $20.90 |
Technical Indicators
Market Signals| Indicator | SOHU | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 39.14 | 18.24 |
| Support Level | $12.41 | N/A |
| Resistance Level | $13.71 | $15.34 |
| Average True Range (ATR) | 0.36 | 0.35 |
| MACD | -0.01 | -0.13 |
| Stochastic Oscillator | 25.51 | 6.62 |
Price Performance
Historical ComparisonAbout SOHU Sohu.com Limited
Sohu.com Ltd provides online media, games, and search products and services on PCs and mobile devices in China. The company operates in Sohu and Changyou segments. Sohu is an online media content and services provider. Through its social features, Sohu also enables users to generate and distribute content, as well as interact with each other on a platform. Changyou is an online game developer and operator. It generates maximum revenue from the Changyou segment.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.